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Abstract 
 
Objective: To explore indirect evidence of reporting biases by examining the distribution of P-
values reported in published medical articles, and to compare P-values distributions across 
different contexts. 
Methods: We selected a random sample (N=1500) of articles published in PubMed in March 
2014. We extracted information on study type, design, medical discipline and P-values for the 
first reported outcome and primary outcome (if specified) from each article. We plotted the 
P-values transformed to the z-score scale and used caliper tests to investigate threshold 
effects. 
Results: Out of the 1500 randomly selected records, 758 (50.5%) were included. We retrieved 
or calculated 758 P-values for first reported outcomes and 389 for primary outcomes 
(specified in only 51% of included studies). The first reported and the primary outcome 
differed in 28% (110/389) of the included studies. The distributions of P-values for first 
reported outcomes and primary outcomes showed a notable discontinuity at the common 
thresholds of statistical significance (P-value=0.05 and P-value=0.01). We also found marked 
discontinuities in the distributions of z-scores across various medical disciplines, study designs 
and types. 
Conclusions: Reporting biases are still common in medical research. We discuss their 
implications, strategies to detect them and recommended practices to avoid them. 
 
Keywords: bias, p-curve, p-hacking, methodology, reporting bias, publication bias 
Work count: Abstract: 198, Main text: 2987, Tables: 2, Figures: 4, References: 40, Appendices: 
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What is new? 
Key finding 
 There are discontinuities in the distributions of p-values from medical 
research studies at the typical thresholds of statistical significance that 
may provide indirect insights on reporting bias 
 Similar results were observed across various study designs and types.  
 
What this study adds to what is known  
 Notable peaks in the distributions at common thresholds of statistical 
significant are consistent with either suppression of non-statistically 
significant results or ‘manipulation’ of reported findings to reach 
statistical significance. 
 The outcome that is reported earliest in an article is more prone to this 
phenomenon than the primary outcome. 
 
 
What is the implication, and what should change now?  
 The present investigation underpins the importance of the efforts and 
initiatives to tackle the mechanisms causing reporting biases (e.g. 
registration of studies, protocols and statistical analysis). 
 Researchers should continue to be encouraged to emphasize confidence 
intervals and effect sizes, rather than P-values, in the interpretation of 
results. 
 There is a need for advocating the importance of replication, as well as 
the benefits of complete publication of research findings to reduce the 
prevalence of reporting biases in scientific literature 
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Introduction 
Complete publication of study results is essential to allow healthcare professionals and policy 
makers to make informed decisions. However, selective or distorted reporting is frequent in 
medical research.[1] Reporting biases arise if dissemination of research findings is influenced 
by the nature of the results. If undetected, reporting biases can lead to inaccurate conclusions 
and inappropriate decisions about health care and resource allocation, with potentially 
serious implications.[2] Failure to publish research findings honestly is unethical and a form of 
research misconduct.[3, 4] Furthermore, research inaccessibility leads to waste of limited 
resources, unnecessary duplication, and loss of trust in scientific integrity.[5] 
 
Reporting biases may impact scientific reports in different ways.[6-9] First, a whole study may 
be suppressed, or harder to find, or published with delay, if its results are not considered to 
be interesting. The label ‘publication bias’ is typically used to refer to this phenomenon.[10] 
Publication bias is the form of reporting bias that has been most extensively discussed in the 
literature over the last 60 years. [11-13] Second, results within a report of a study may be 
biased if the authors report the most interesting findings. For example, they may report the 
finding with smallest P-value or largest effect estimate after performing several analyses on 
the same outcome. Several terms have been coined to refer to such practice, including 
selective analysis reporting, data dredging and p-hacking.[14] Alternatively, some outcomes 
that were measured and analysed may be missing if the authors did not consider the results 
to be interesting.  
 
Although these reporting biases are likely to have been always present in the dissemination of 
research findings, more attention has been drawn to them recently due to the widespread 
use of systematic reviews. The validity of conclusions drawn from systematic reviews, 
intended to summarize the state of the art in a scientific area, is threatened if published 
results are not representative of the population of all conducted studies and analyses. Meta-
analysis provides researchers with several graphical methods and statistical tests to assess the 
possible presence of reporting biases.[6, 10, 13, 15] The exponential growth of published 
meta-analyses, many of them including some assessment of reporting biases, is likely to have 
increased the concern of incomplete publication of results as an ubiquitous problem in the 
scientific literature.[8]  
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Evidence of reporting biases can be direct or indirect. Direct evidence includes tracking of 
cohorts of registered studies or conference proceeding abstracts and comparing the results of 
published and unpublished findings. For instance, studies have provided empirical evidence 
that studies with significant or positive results were more likely to be published, or more likely 
to be published earlier, than those with non-significant or unimportant results. [5, 8] Direct 
evidence may also come from the acknowledgement of bias by those involved in the 
publication process, such as researchers, referees and editors.[16] 
 
Indirect sources of evidence of reporting biases include the observation of a 
disproportionately high percentage of statistically significant findings in the published 
literature, as well as notable discontinuities in the P-value distribution curve just above the 
main significance thresholds (p=0.05). Several papers have been published illustrating similar 
approaches in psychology, sociology and natural science.[14, 17-19] Here we aim to explore 
indirect evidence of reporting biases by examining the empirical distribution of P-values 
reported in a large set of medical research studies, and to compare this distribution across 
different contexts. 
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Methods 
Study eligibility and selection 
We conducted a descriptive cross-sectional survey of peer-reviewed, published, medical 
research articles. We sought original, primary and quantitative research articles, and searched 
the PubMed database using a simple search strategy that would identify most of these 
(Appendix 1). We restricted the search to articles published in March 2014, and selected a 
random sample of 1500 of the identified articles. To be included in the analyses, articles had 
to be written in English and had to involve only human participants. Articles had to include 
inferential statistics that investigated the efficacy or side effects of a medical or surgical 
intervention; or investigating risk factors, exposures or prognostic factors (epidemiological 
associations). We considered a wide range of study designs including randomized clinical 
trials, controlled clinical trials, before-after trials, cohort studies, case-control studies and 
cross-sectional studies, and we considered a wide range of estimates including differences in 
means, risk ratios, odds ratios, hazard ratios, correlations and regression coefficients. We 
included only articles that either reported the P-value or provided sufficient information to 
calculate a P-value for either the first reported or the primary outcome. We excluded 
duplicate reports of the same study as well as inaccessible full-text articles (e.g. published 
abstracts without full articles, or study protocols). 
 
Data screening and extraction 
We developed a standardised data extraction form, which was pilot-tested by all members of 
the research team.  We extracted data based on the first reported outcome in the abstract 
(preferentially) or in the results section. For each included article, we extracted the following 
information:  
 Author list and citation details. 
 Medical speciality: we used the categories suggested by Davey et al.[20] 
 Study type: therapeutic/intervention, prognostic, aetiological/risk factor. 
 Study design: we used the classification used by Grimes et al:[21] randomized 
controlled trial (RCT), non-RCT, cohort, case-control, cross-sectional. 
 Sample size: total sample size used in the analysis which yielded the P-value. 
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 Whether the primary outcome was specified (we considered the primary outcome to 
be specified if the authors had explicitly stated/labelled the primary outcome in the 
published report) (Yes/No) and whether it was the same as the first reported outcome 
(Yes/No/Unclear). 
 2-sided P-value, or information sufficient to calculate it, for the first reported outcome 
and for the primary outcome (if specified). We used the following hierarchy to 
determine each P-value, where only one of the following types of information was 
required: 
1. Exact 2-sided P-value: from the hypothesis test. 
2. Effect estimate with standard error or confidence limits: We used methods 
described by Altman and Bland to calculate P-values[22] from these measures. 
3. Test statistics: Z, chi-squared, t or F statistic, with degrees of freedom if 
applicable. 
4. For two-group designs reporting continuous outcome data: sample size, mean 
and standard deviation (or standard error) for each group. 
5. For studies reporting dichotomous outcome data: contingency table (e.g. 2×2 
table). 
Where a specified primary outcome differed from the first reported one, we implemented 
the same hierarchy to extract a P-value for each of the two outcomes. 
 
Data analysis 
As a first step, we transformed the two-sided p-values into absolute z-scores, and used the 
latter as our main dependent variable. We plotted the distribution of z-scores across all 
included studied, both for first reported outcomes and for primary outcomes, using 
histograms. In the absence of any bias and if all effects are truly null, these scores would have 
a standard half normal distribution. In the presence of genuine effects in some (or all) studies, 
we would expect the distribution to be shifted to the right and no longer half normal. 
Furthermore, in the absence of reporting biases the distribution should be free of sharp 
discontinuities.  
We repeated these plots with subsets of the studies to explore the distributions of z-scores 
stratified by medical specialty, study design and study type. Moreover, we used the caliper 
test described by Gerber and Malhotra  to explore the existence of discontinuities in the 
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distribution of z-scores around the critical values of 1.96 and 2.576[19]. We compared the 
frequency of values in equal sized intervals just below and just above the threshold values 
commonly used for statistical significance (0.01 and 0.05) for first reported and primary 
outcomes, using a chi-squared test. We performed all analyses using the R statistical software 
(version 3.2.3).[23] 
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Results 
Description of included studies 
Figure 1 displays the study selection process in a flow chart. Of the 1500 randomly selected 
articles, we included 758 (50.5%). Among these included articles, 422 (56%) described 
therapeutic/intervention studies, 207 (27%) were aetiological/risk factor studies, and 129 
(17%) were prognostic studies. With regards to study design, 264 (35%) were RCTs, 53 (7%) 
were non-RCTs, 145 (19%) were cross-sectional, 238 (32%) were cohort and 55 (7%) were 
case-control studies.  
The medical disciplines of the included articles were cancer (N=105; 14%), cardiovascular 
(N=116; 15%), central nervous system/musculoskeletal (N=97; 13%), digestive, endocrine, 
nutritional and metabolic (N=98; 13%), gynaecology/pregnancy/birth (N=58; 8%), infectious 
(N=44; 6%), mental health/behavioural (N=75; 10%), urogenital (N=33; 4%), respiratory 
(N=21; 3%) and other disorders (N=111; 14%). The sample size of all included studies ranged 
from 6 to 375,888, with a median of 142 participants (range 55-525; IQR=470).  
Out of the 264 included RCTs, the primary outcome was specified in 190 (72%). The primary 
outcome was also the first reported outcome in 143 (75%) studies, while it was not the first 
reported outcome in 45 (24%) and unclear in 2 (1%). In studies other than RCTs, the primary 
outcome was specified only in 199 out of 494 included studies (40%). The primary outcome 
was also the first reported outcome in 133 (67%) studies, while it was not the first reported 
outcome in 65 (33%) and unclear in one study. 
The 742 excluded articles comprised 245 (33%) with only descriptive statistics, 144 (19%) with 
no original data, 121 (16%) with inaccessible full texts, 84 (11%) that were diagnostic or cost-
analysis studies, 58 (8%) without sufficient information to extract or calculate a P-value, 48 
(7%) with non-human research participants and 42 (6%) that were qualitative. 
 
Empirical distribution of z-scores and p-values 
We retrieved 758 results for first reported outcomes, with a median P-value of 0.011 and P-
values of 0.0006 and 0.045 for the first and third quartiles, respectively. Figure 2 shows the 
distribution of z-scores for first reported outcomes and primary outcomes, with dashed 
vertical lines for the common thresholds of z = 1.96 and z = 2.576 (corresponding to p = 0.05 
and p = 0.01, respectively) for statistical significance. In both distributions, there is a  clear 
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majority of z-scores above the threshold levels. Of particular note is the dramatic spike in the 
frequency of z-scores just over the significance threshold z-score of 1.96 and 2.576. The 
results of the caliper tests using 5% and 10% caliper sizes for the first reported outcomes as 
well as primary outcomes showed a notable imbalance in the numbers of findings around the 
common significance threshold of 1.96 (P-value = 0.05), which is evident across the two 
caliper sizes (5% and 10%) in both first reported outcomes and primary outcomes (Table 1). 
When using a significance threshold of 2.576, there was also a significant inbalance in the 
number of findings for both first reported and primary outcomes using the 5% caliper size, 
but not using the 10% size. 
Table 2 shows that the majority of the retrieved P-values (both for first reported and primary 
outcomes) were smaller than common significance thresholds (0.05 and 0.01) with a total of 
592 (78%) P-values of first reported outcomes were equal to or smaller than 0.05, and 376 
(50%) were also equal to or smaller than 0.01. 
The distribution of P-values reported in included studies for the first reported outcomes 
compared with the primary outcomes and grouped by study design (RCTs vs. studies other 
than RCTs). It shows that P-values more likely to be significant for the first reported outcomes 
than for the primary outcomes in RCTs only (p-value = 0.02391) (Table 3). 
 
Stratified analyses 
Figure 3 shows the histograms of z-scores for first reported outcomes stratified by medical 
speciality, annotated by median sample sizes within specialties. All figures reflect the same 
pattern of a majority of z-scores over the threshold of statistical significance, but the 
distributions appear less skewed in some of the disciplines with larger average sample sizes, 
namely infectious diseases (N=28; 63.6% of z-scores above 1.96), urogenital (N=21;  63.6%) 
and cancer (N=75; 71.4%). The most extreme patterns appeared in the area of respiratory 
diseases (N=19; 90.5% of z-scores above 1.96), cardiovascular (N=97; 83.6%) and central 
nervous system or musculoskeletal disorders (N=78; 80.4%). Similar trends were observed in 
the histograms of z-scores for primary outcomes stratified by medical speciality, which are 
provided in Appendix 2. 
 
Histograms of z-scores for first reported outcomes did not show major differences in the 
distribution according to study design (Figure 4). Likewise, we obtained similar histograms 
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when exploring the distributions of z-scores for first reported outcomes stratified by study 
type, and also when plotting the distributions of z-scores for primary outcomes stratified by 
study design or by study type (Appendix 2).  
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Discussion 
Our distributions of reported P-values from medical research studies show notable peaks (or 
discontinuities) in the distributions at the common thresholds of statistical significance (p = 
0.05 and p = 0.01) that may provide indirect insights on reporting bias. The outcome that is 
reported earliest in an article is more prone to this phenomenon than the primary outcome. 
Only about half of the included articles specified the primary outcome, and in 28% of the 
articles the first reported outcome was not the primary outcome. Similar patterns were 
observed across various medical discplines, study designs and types. 
 
Strengths of our study include use of a large random sample of 1500 articles recently 
published, of which 758 contributed to the analysis. We also implemented manual data 
extraction from the articles; provided a breakdown by medical disciplines, study type and 
study design; and computed P-values when they were not reported directly. However, we 
were unable to retrieve all of the articles listed in our random sample (see Figure 1). We are 
unable to draw any conclusions about whether the observed distribution is due to data 
manipulation (‘p-hacking’) or genuine effects, because as Bruns and Ioannidis suggested[24], 
p-curves may neither identify genuine effects nor p-hacking in observational research.   
 
The presence of reporting biases has been claimed repeatedly in the medical literature,[1, 4, 
8] and in other areas as diverse as cognitive sciences,[17, 25] biology,[26] educational 
research,[27] political sciences,[28] and management research.[7] Although definitions of 
reporting biases and strategies to explore vary, the conclusions and implications for 
researchers are similar across disciplines. Previous studies have investigated empirical 
distributions of published P-values. A study of abstracts in PubMed reported an extremely 
skewed distribution of P-values, with a substantially higher proportion of P-values below 0.05 
in non-randomized studies compared to randomized trials.[29] In a review of meta-analyses, 
Ioannidis and Trikalinos also concluded that significant P-values were overrepresented [30]. In 
psychology, some studies also explored the P-value distribution and showed an inordinately 
high number of P-values just below 0.05.[17, 31]  
 
It is good practice to specify the primary outcome before performing the statistical analysis of 
a clinical trial.[9] In our survey, we found that 72% of the RCTs vs. 40% of studies other than 
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RCTs specified the primary outcome in their reports. Moreover, the specified primary 
outcome and first reported outcome differed in 24% of the included RCTs compared with 
33% in the included studies other than RCTs. In addition, we found that the proportion of 
significant P-values is higher in first reported outcomes compared with primary outcomes in 
RCTs. This is consistent with observations in epidemiological research comparing primary 
outcomes stated in the protocol with those declared in the final report.[32, 33]  
 
Reporting biases are a prevalent and complex phenomenon across most scientific areas, 
including epidemiology. Our survey adds to the evidence that statistically significant findings 
are still overrepresented in current medical research. The phenomenon limits the validity of 
conclusions drawn from the published literature, and has led to expressions of major 
concerns and disbelief about the usefulness of scientific evidence.[34, 35] It is important that 
techniques are used to assess the potential extent of these threats to published evidence, 
whether in the context of a systematic review or otherwise. Meta-analysis methods provide 
some of the most direct tools for this, although have major limitations. 
 
Efforts should be increased to tackle the mechanisms causing reporting biases. Initiatives to 
facilitate registration of studies, protocols and statistical analysis plans are key in this regard. 
The common practice of interpreting results based on significance tests is likely to have an 
important role, and researchers should continue to be encouraged to emphasize confidence 
intervals and effect sizes, rather than P-values, in the interpretation of results.[22, 36, 37] 
Furthermore, the pressure imposed on researchers to produce scientific publications on a 
regular basis, coupled with the increasing emphasis on research impact (including journal 
impact factor), may lead them to dismiss scientific findings for publication if their results are 
insufficiently innovative or not in agreement with the dominant paradigm. This risks a 
prioritization of aspects other than rigor and scientific quality when presenting their findings 
in scientific reports.[38] A new framework in which the importance of replication, as well as 
the benefits of complete publication of research findings, has been advocated as a promising 
approach to reduce the prevalence of reporting biases in scientific literature.[25, 39, 40] 
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Tables  
Table 1. Caliper test for reporting biases in first reported outcomes and primary outcomes. 
 
In a bilateral test, z=1.96 and z=2.576 correspond to p=0.05 and p=0.01, respectively; Under caliper: number of z-scores 
that are between 0 and X% smaller than the threshold value, with X being the caliper size; Over caliper: number of z-scores 
that are between 0 and X% greater than the threshold value; P-value: p-value from a one-tailed binomial test 
  
 5% caliper 10% caliper 
Under 
caliper 
Over 
caliper 
P-value Under 
caliper 
Over 
caliper 
P-value 
Threshold z=1.96 
First reported 
outcomes 
17 44 <.001 24 60 <.001 
Primary 
outcomes 
9 23 0.010 13 35 0.001 
Threshold z=2.576 
First reported 
outcomes 
31 55 0.006 84 81 0.622 
Primary 
outcomes 
14 28 0.022 40 34 0.792 
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Table 2. Distribution of P-values for all first reported outcomes and primary outcomes. 
 
 
 
 
 
 
 
The distribution of the P-values for the first reported outcomes compared to 
primary outcomes was performed by the analysis of frequencies (χ2
2 = 10.412; p-
value = 0.005).  
 
 
  
 P-values 
>0.05 
P-values 
0.05 & >0.01 
P-values 
0.01 
First reported 
outcomes 
166 (21.9%) 216 (28.5%) 376 (49.6%) 
Primary 
outcomes 
118 (30.6%) 101 (26.2%) 167 (43.3%) 
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Table 3. Distribution of P-values for all first reported outcomes and primary outcome 
grouped by the study design (RCTs vs. studies other than RCTs). 
 
 
The distribution of the P-values for the first reported outcomes compared to primary outcomes was performed by the 
analysis of frequencies in included a RCTs (𝜒2
2 = 7.4666; p-value = 0.0239); b Studies other than RCTs (𝜒2
2 = 1.2052; p-value = 
0.5474).  
 
 
 
 
  
 P-values from RCTs P-values from studies other than RCTs 
 >0.05 0.05 & 
>0.01 
0.01 >0.05 0.05 & 
>0.01 
0.01 
First reported 
outcomesa 
71  
(26.9%) 
77  
(29.2%) 
116 
(43.9%) 
96  
(19.4%) 
139 
(28.1%) 
259 
(52.4%) 
Primary 
outcomesb 
73  
(38.6%) 
51  
(27.0%) 
65  
(34.4%) 
45  
(22.8%) 
50  
(25.4%) 
102 
(51.8%) 
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Figures 
 
 
 
Figure 1. Flow chart for identification of relevant articles from a random sample of records 
in PubMed  
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Figure 2. Histograms of z-scores across all articles 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the red dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests. 
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Figure 3. Histograms of z-scores for first reported outcomes, stratified by medical 
discipline.  
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies; N: sample 
size. 
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Figure 4. Histograms of z-scores for first reported outcomes, stratified by study design 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies. 
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Appendices 
Appendix 1. Search strategy for PubMed/Medline 
1. "2014/03/01"[Date - Publication] : "2014/03/31"[Date - Publication] 
2. Clinical Trial[ptyp]  
3. Clinical Trial, Phase III[ptyp]  
4. Comparative Study[ptyp]  
5. Controlled Clinical Trial[ptyp]  
6. Multicenter Study[ptyp]  
7. Observational Study[ptyp]  
8. Randomized Controlled Trial[ptyp]  
9. Pragmatic Clinical Trial[ptyp]  
10. Twin Study[ptyp] 
11. 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 
12. Humans[Mesh]  
13. English[lang] 
14. 1 AND 11 AND 12 AND 13 
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Appendix 2. Supplementary figures 
 
 
Figure S1. Histograms of z-scores for primary outcomes, stratified by medical discipline 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies; N: sample 
size. 
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Figure S2. Histograms of z-scores for first reported outcomes, stratified by study type 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies. 
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Figure S3. Histograms of z-scores for primary outcomes, stratified by the study design 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies. 
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Figure S4. Histograms of z-scores for primary outcomes, stratified by the study type 
These figures display z-scores in absolute value, with the bottom x-axis indicating the 
corresponding p-value in a two-tailed test; the dashed lines represent the common 
thresholds of p = 0.05 and p = 0.01 for significance tests; k: number of studies. 
 
